micro-community-banner
Profile Image
  • Saved

A single high-salt meal may trigger cortisol and ACTH responses, suggesting a possible hormonal link between salt intake and obesity, warranting further investigation into this novel mechanism.

Profile Image
  • Saved
Salt-Sensitive Hypertension and the Kidney - PubMed

Salt-Sensitive Hypertension and the Kidney - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38545804/

Salt-sensitive hypertension (SS-HT) is characterized by blood pressure elevation in response to high dietary salt intake and is considered to increase the risk of cardiovascular and renal morbidity. Although the...

Salt-sensitive hypertension is driven by impaired renal sodium handling and aberrant hormonal responses, exacerbated by obesity and aging, highlighting the kidney’s central role in salt-induced blood pressure elevation.

Profile Image
  • Saved
Obesity-induced tissue alterations resist weight loss: A mechanistic review - PubMed

Obesity-induced tissue alterations resist weight loss: A mechanistic review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38720199/

Interventions aimed at weight control often have limited effectiveness in combating obesity. This review explores how obesity-induced dysfunction in white (WAT) and brown adipose tissue (BAT), skeletal muscle, and the...

Obesity-induced dysfunction in adipose tissue, muscle, and brain impairs lipolysis, thermogenesis, metabolism, and satiety signaling, collectively hindering effective, sustained weight loss despite common intervention strategies.

Profile Image
  • Saved
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity - PubMed

Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39295512/

The rapid and widespread clinical adoption of highly effective incretin-mimetic drugs (IMDs), particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the updating of clinical practice guidelines. Consequently,...

Rapid adoption of incretin-mimetic drugs for obesity risks muscle loss; combining adequate protein, micronutrients, and resistance training is essential to preserve muscle mass and optimize treatment benefits.

Profile Image
  • Saved
Obesity: Next game changer of allergic airway diseases? - PubMed

Obesity: Next game changer of allergic airway diseases? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40329860/

Obesity and allergic diseases are global health concerns, both of which are seeing an increase in prevalence in recent years. Obesity has been recognised as an important comorbidity in subpopulations...

Obesity exacerbates allergic airway diseases by altering immune endotypes, increasing severity, and reducing treatment response, necessitating weight loss strategies and personalized therapeutic approaches for effective management.

Profile Image